MX2016012288A - Metodos para preparar un poloxamero para usar en medio de cultivo celular. - Google Patents
Metodos para preparar un poloxamero para usar en medio de cultivo celular.Info
- Publication number
- MX2016012288A MX2016012288A MX2016012288A MX2016012288A MX2016012288A MX 2016012288 A MX2016012288 A MX 2016012288A MX 2016012288 A MX2016012288 A MX 2016012288A MX 2016012288 A MX2016012288 A MX 2016012288A MX 2016012288 A MX2016012288 A MX 2016012288A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- poloxamer
- cell culture
- preparing
- culture medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/50—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing nitrogen, e.g. polyetheramines or Jeffamines(r)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970281P | 2014-03-25 | 2014-03-25 | |
| PCT/US2015/022592 WO2015148736A1 (en) | 2014-03-25 | 2015-03-25 | Methods of preparing a poloxamer for use in cell culture medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016012288A true MX2016012288A (es) | 2017-01-23 |
Family
ID=52824596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016012288A MX2016012288A (es) | 2014-03-25 | 2015-03-25 | Metodos para preparar un poloxamero para usar en medio de cultivo celular. |
| MX2021001981A MX2021001981A (es) | 2014-03-25 | 2016-09-22 | Metodos para preparar un poloxamero para usar en medio de cultivo celular. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021001981A MX2021001981A (es) | 2014-03-25 | 2016-09-22 | Metodos para preparar un poloxamero para usar en medio de cultivo celular. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11034793B2 (enExample) |
| EP (2) | EP3778702B1 (enExample) |
| JP (3) | JP6655548B2 (enExample) |
| KR (1) | KR102352250B1 (enExample) |
| CN (2) | CN106414552B (enExample) |
| AU (1) | AU2015236008B2 (enExample) |
| BR (1) | BR112016021739B1 (enExample) |
| CA (1) | CA2943357C (enExample) |
| ES (1) | ES2778680T3 (enExample) |
| HR (1) | HRP20200372T1 (enExample) |
| IL (2) | IL247902B (enExample) |
| MX (2) | MX2016012288A (enExample) |
| MY (1) | MY178060A (enExample) |
| PL (1) | PL3122799T3 (enExample) |
| RU (1) | RU2710551C2 (enExample) |
| SG (1) | SG11201607929PA (enExample) |
| SI (1) | SI3122799T1 (enExample) |
| WO (1) | WO2015148736A1 (enExample) |
| ZA (1) | ZA201606711B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106414552B (zh) | 2014-03-25 | 2020-08-25 | 豪夫迈·罗氏有限公司 | 制备用于细胞培养基中的泊洛沙姆的方法 |
| JP7037495B2 (ja) * | 2016-03-17 | 2022-03-16 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | ポロキサマーを精製するための方法 |
| KR102544922B1 (ko) * | 2017-12-21 | 2023-06-16 | 시그마-알드리치 컴퍼니., 엘엘씨 | 폴록사머 조성물 및 이의 제조 및 사용 방법 |
| RU2741710C1 (ru) * | 2018-07-12 | 2021-01-28 | Елена Валентиновна Аршинцева | Термический способ стерилизации жидких лекарственных средств, содержащих в своем составе полоксамер |
| JPWO2020022511A1 (ja) * | 2018-07-27 | 2021-08-02 | 味の素株式会社 | 動物細胞の浮遊培養用の添加物、浮遊培養用培地および浮遊培養方法 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE266710C (enExample) | ||||
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| AU632065B2 (en) * | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| CA2050918A1 (en) | 1990-01-12 | 1991-07-13 | Raju Kucherlapati | Generation of xenogeneic antibodies |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DE69133476T2 (de) | 1990-08-29 | 2006-01-05 | GenPharm International, Inc., Palo Alto | Transgene Mäuse fähig zur Produktion heterologer Antikörper |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| FI941538A7 (fi) | 1991-10-04 | 1994-05-31 | Gs Dev Ab | Partikkelit, menetelmä niiden valmistamiseksi ja niiden käyttö |
| DK0754050T3 (da) * | 1994-01-14 | 2002-10-21 | Xoma Technology Ltd | Anti-gram-positive bakterielle fremgangsmåder og materialer |
| US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DK1500329T3 (da) | 1996-12-03 | 2012-07-09 | Amgen Fremont Inc | Humane antistoffer, der specifikt binder TNF-alfa |
| GB9625175D0 (en) * | 1996-12-04 | 1997-01-22 | Medi Cult As | Serum-free cell culture media |
| US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| ES2248127T3 (es) | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| ES2695401T3 (es) * | 2003-02-12 | 2019-01-04 | Syncera Inc | Composiciones de aleación de polímeros de óxido de alquileno aleatorios y no aleatorios |
| US8802116B2 (en) * | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
| AU2003900887A0 (en) * | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
| WO2005014163A1 (en) | 2003-08-04 | 2005-02-17 | Camurus Ab | Method for loading amphiphile particles with active agents |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| WO2006044738A2 (en) | 2004-10-18 | 2006-04-27 | Maroon Biotech Corporation | Methods and compositions for treatment of free radical injury |
| US9149433B2 (en) * | 2004-11-30 | 2015-10-06 | Basf Corporation | Method for formation of micro-prilled polymers |
| CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
| EP2054040B1 (en) * | 2006-08-16 | 2011-03-30 | Novartis AG | Method for making solid dispersions of midostaurin |
| KR100932613B1 (ko) | 2007-04-27 | 2009-12-17 | 한남대학교 산학협력단 | 고분자 용융공정을 이용한 약물전달용 생체적합성 고분자나노 미립구의 제조방법 및 그 나노 미립구 |
| WO2009055312A1 (en) * | 2007-10-22 | 2009-04-30 | Dfb Pharmaceuticals, Inc. | Process for producing a poloxamer gel |
| DK2235197T3 (en) * | 2007-12-27 | 2017-10-09 | Baxalta GmbH | Methods of cell culture |
| MX2012007117A (es) * | 2009-12-23 | 2012-07-23 | Sanofi Pasteur | Metodo para cultivar celulas adherentes. |
| JP6177873B2 (ja) * | 2012-03-30 | 2017-08-09 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ミクロスフィア組成物、その調製方法及び用途 |
| CN106414552B (zh) * | 2014-03-25 | 2020-08-25 | 豪夫迈·罗氏有限公司 | 制备用于细胞培养基中的泊洛沙姆的方法 |
-
2015
- 2015-03-25 CN CN201580026701.5A patent/CN106414552B/zh active Active
- 2015-03-25 WO PCT/US2015/022592 patent/WO2015148736A1/en not_active Ceased
- 2015-03-25 MX MX2016012288A patent/MX2016012288A/es unknown
- 2015-03-25 EP EP20151556.6A patent/EP3778702B1/en active Active
- 2015-03-25 SI SI201531128T patent/SI3122799T1/sl unknown
- 2015-03-25 ES ES15715932T patent/ES2778680T3/es active Active
- 2015-03-25 CN CN202010723304.6A patent/CN111808276A/zh active Pending
- 2015-03-25 MY MYPI2016001715A patent/MY178060A/en unknown
- 2015-03-25 RU RU2016141568A patent/RU2710551C2/ru active
- 2015-03-25 AU AU2015236008A patent/AU2015236008B2/en active Active
- 2015-03-25 JP JP2016558605A patent/JP6655548B2/ja active Active
- 2015-03-25 BR BR112016021739-0A patent/BR112016021739B1/pt active IP Right Grant
- 2015-03-25 CA CA2943357A patent/CA2943357C/en active Active
- 2015-03-25 EP EP15715932.8A patent/EP3122799B8/en active Active
- 2015-03-25 SG SG11201607929PA patent/SG11201607929PA/en unknown
- 2015-03-25 PL PL15715932T patent/PL3122799T3/pl unknown
- 2015-03-25 HR HRP20200372TT patent/HRP20200372T1/hr unknown
- 2015-03-25 KR KR1020167029244A patent/KR102352250B1/ko active Active
-
2016
- 2016-09-19 IL IL247902A patent/IL247902B/en active IP Right Grant
- 2016-09-22 US US15/273,155 patent/US11034793B2/en active Active
- 2016-09-22 MX MX2021001981A patent/MX2021001981A/es unknown
- 2016-09-28 ZA ZA2016/06711A patent/ZA201606711B/en unknown
-
2020
- 2020-02-04 JP JP2020017136A patent/JP2020103290A/ja not_active Withdrawn
- 2020-12-20 IL IL279583A patent/IL279583B/en unknown
-
2021
- 2021-05-13 US US17/319,886 patent/US11912823B2/en active Active
-
2022
- 2022-09-30 JP JP2022157928A patent/JP7472222B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019003427A (es) | Composiciones para cultivo celular y metodos para la produccion de polipeptidos. | |
| SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
| MX2020009670A (es) | Metodos de cultivo por perfusion y usos de los mismos. | |
| EP3161127A4 (en) | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof | |
| MX2021008143A (es) | Metodos para cosechar cultivos de celulas de mamifero. | |
| GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
| TR201904270T4 (tr) | Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller. | |
| EP3263697A4 (en) | Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell | |
| MX366112B (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| EP3495467A4 (en) | METHOD AND DEVICE FOR PRODUCING A CONTAINER, CELL CULTURE VESSEL, METHOD FOR CULTIVATING CELLS, METHOD FOR PRODUCING A CELL CULTURE VESSEL AND DEVICE FOR PRODUCING A CELL CULTURE VESSEL | |
| EP3184627A4 (en) | Culture medium for mesenchymal stem cells | |
| EP3124602A4 (en) | Culture medium for pluripotent stem cells | |
| HK1220404A1 (zh) | 用於细胞培养的细胞外基质组合物珠粒 | |
| MX2021001981A (es) | Metodos para preparar un poloxamero para usar en medio de cultivo celular. | |
| MX2021007433A (es) | Metodos de cultivo de una celula de mamifero. | |
| EP3162892A4 (en) | Method for culturing adhesive cells, culture vessel, and method for producing protein | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| EP3693452A4 (en) | CELL CULTURE CONTAINER, CELL ACQUISITION PROCESS AND CELL CULTURE PROCESS | |
| EP3181686A4 (en) | Culture medium and method for enriching and maintaining cancer stem cells (cscs) using said medium | |
| EP3252146A4 (en) | Medium composition for culturing stem cells | |
| MX2022000516A (es) | Metodos relacionados con celulas pluripotentes. | |
| EP3144382A4 (en) | Method for producing lactic acid bacteria medium, method for culturing lactic acid bacteria using same, and lactic acid bacteria powder using lactic acid bacteria obtained by said culture method | |
| EP3194573A4 (en) | Mammalian pluripotent stem cells, methods for their production, and uses thereof | |
| MX2017008289A (es) | Metodos para aumentar la estabilidad de la produccion de compuestos en celulas huesped microbianas. | |
| EP3150700A4 (en) | Culture medium and culturing method for anchorage-dependent cells, cell composition including stem cells and/or differentiated cells derived from stem cells, and production method for cell composition |